Dana Farber/Harvard Cancer Center

Latest stories

12d
News-Medical-Net
BCL-2 inhibitor shows promise in AML patientsBottom Line: Patients whose acute myelogenous leukemia (AML) had relapsed or wa
BCL-2 inhibitor shows promise in AML patients
News-Medical-Net / Posted 12 days ago
Bottom Line: Patients whose acute myelogenous leukemia (AML) had relapsed or was resistant to chemotherapy and those who were deemed unable to tolerate chemotherapy experienced responses to the selective BCL-2 inhibitor venetoclax (Venclexta), with... Read more
13d
News-Medical-Net
Pancreatic cancer cells find alternative source of nutrition to avoid starvationPancreatic cancer cells avert starvation in dense tumors by ordering nearby sup
Pancreatic cancer cells find alternative source of nutrition to avoid starvation
News-Medical-Net / Posted 13 days ago
Pancreatic cancer cells avert starvation in dense tumors by ordering nearby support cells to supply them with an alternative source of nutrition. This is the finding of a study in cancer cells and mice published August 10 in Nature. The study was led... Read more
14d
Medical News Today
Colorectal tumors exacerbated by mouth microbesMouth microbes called fusobacteria may use the bloodstream to reach and worsen
Colorectal tumors exacerbated by mouth microbes
Medical News Today / Posted 14 days ago
Mouth microbes called fusobacteria may use the bloodstream to reach and worsen colorectal tumors through a special sugar-binding protein, study finds. Fusobacteria, most commonly found in the mouth, use a sugar-binding protein to stick to developing... Read more
17d
Boston Globe
Lab is liquidated, and so is decade of cancer studiesLynn Hlatky has spent her career as a scientist studying the development of can
Lab is liquidated, and so is decade of cancer studies
Boston Globe / Posted 17 days ago
Lynn Hlatky has spent her career as a scientist studying the development of cancer, hoping in some way to improve understanding of an insidious disease. She took a path common in her field: won funding, established a lab, assembled a team of... Read more
21d
News-Medical-Net
PD-1-responsive T cells may offer clues to design more effective drugs for cancerCancer immunotherapy drugs that block the inhibitory PD-1 pathway have shown su
PD-1-responsive T cells may offer clues to design more effective drugs for cancer
News-Medical-Net / Posted 21 days ago
Cancer immunotherapy drugs that block the inhibitory PD-1 pathway have shown success in clinical trials and are now FDA-approved for melanoma, lung cancer and bladder cancer. Yet many patients' tumors do not respond to these drugs. Scientists from... Read more
27d
Bel Marra Health
Prostate cancer 2016: Metastatic prostate cancer cases grow, Alzheimer’s disease risk, heart failure, and heart attack mortalityProstate Cancer 2016 update: We have compiled a list of our top news stories re
Prostate cancer 2016: Metastatic prostate cancer cases grow, Alzheimer’s disease risk, heart failure, and heart attack mortality
Bel Marra Health / Posted 27 days ago
Prostate Cancer 2016 update: We have compiled a list of our top news stories regarding prostate cancer and other related health problems including metastatic prostate cancer, Alzheimer’s disease, heart failure and heart attack. Prostate cancer may... Read more

People in this news